Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Delayed Nyse  -  04:00 2022-09-26 pm EDT
231.64 USD   -0.97%
09/26Becton, Dickinson, CerTest Biotec Launch Research-Use-Only Monkeypox Assay
MT
09/26BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay
PR
09/23Becton Dickinson & Co : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Transcript : Becton, Dickinson and Company, Q3 2022 Earnings Call, Aug 04, 2022

08/04/2022 | 08:00am EDT
Hello, and welcome to BD's Earnings Call for the Third Quarter of Fiscal 2022. At the request of BD, today's call is being recorded and will be made available for replay through August 11, 2022 on...


© S&P Capital IQ 2022
All news about BECTON, DICKINSON AND COMPANY
09/26Becton, Dickinson, CerTest Biotec Launch Research-Use-Only Monkeypox Assay
MT
09/26BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay
PR
09/23Becton Dickinson & Co : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F..
AQ
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/13BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Effic..
PR
09/13Becton, Dickinson and Company Launches Next Generation Prefillable Vaccine Syringe Desi..
CI
09/09BD Appoints Two Business Unit Presidents
AQ
09/08BECTON, DICKINSON AND COMPANY : Ex-dividend day for
FA
09/07Transcript : Becton, Dickinson and Company Presents at 2022 Wells Fargo Healt..
CI
09/01Fitch Maintains Evolving Ratings Watch on Bausch + Lomb's Ratings Watch
AQ
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 18 849 M - -
Net income 2022 1 866 M - -
Net Debt 2022 13 443 M - -
P/E ratio 2022 33,9x
Yield 2022 1,63%
Capitalization 66 063 M 66 063 M -
EV / Sales 2022 4,22x
EV / Sales 2023 4,02x
Nbr of Employees 75 000
Free-Float 77,6%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 231,64 $
Average target price 278,08 $
Spread / Average Target 20,0%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Christopher J. DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Elizabeth McCombs Senior Vice President-Research & Development
Joseph M. Smith Chief Scientific Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY-4.82%66 063
ABBOTT LABORATORIES-29.06%176 313
MEDTRONIC PLC-21.38%109 868
HOYA CORPORATION-17.56%35 356
DEXCOM, INC.-40.14%31 666
AMERISOURCEBERGEN CORPORATION2.60%28 436